• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺罗定对毛霉目真菌的抗真菌活性:对临床分离株的体外研究。

Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates.

作者信息

Jafarian Hadis, Amanati Ali, Badiee Parisa

机构信息

Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Curr Med Mycol. 2022 Mar;8(1):26-31. doi: 10.18502/cmm.8.1.9211.

DOI:10.18502/cmm.8.1.9211
PMID:36340433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9548082/
Abstract

BACKGROUND AND PURPOSE

Taurolidine is active against a wide variety of micro-organisms, including bacteria and fungi. Mucormycosis is one of the life-threatening opportunistic fungal infections, especially in immunocompromised patients. Currently, the emergence of Mucormycosis during the COVID-19 pandemic raises public health concerns regarding untoward morbidity and mortality among SARS-CoV-2 patients. It is well-known that delayed and inappropriate antifungal therapy leads to increased morbidity and mortality. This study aimed to investigate the antifungal activity of taurolidine to evaluate its effects against clinical isolates of .

MATERIALS AND METHODS

This study included previously collected clinical isolates. The minimum inhibitory concentration (MIC) of amphotericin B, caspofungin, voriconazole, posaconazole, and itraconazole was determined using the broth microdilution method.

RESULTS

All clinical isolates showed full sensitivity to amphotericin B. Posaconazole MIC range from 8 μg/mL to 0.032‎ μg/mL. The MIC range of voriconazole and caspofungin were determined to be 2-8 µg/mL and 0.5-16 µg/mL, respectively. Growth of the isolates was entirely inhibited in 1000 µg/mL concentration of taurolidine. In microscopic observations, morphological effects on hyphal growth were observed at 500 µg/mL concentration.

CONCLUSION

In conclusion, this is an updated experience of using taurolidine against . However, our in-vitro findings need to be confirmed in well-designed clinical trials aimed at treating invasive Mucormycosis infections.

摘要

背景与目的

牛磺罗定对多种微生物具有活性,包括细菌和真菌。毛霉病是一种危及生命的机会性真菌感染,尤其是在免疫功能低下的患者中。目前,在新冠疫情期间毛霉病的出现引发了公众对新冠患者不良发病率和死亡率的健康担忧。众所周知,延迟和不适当的抗真菌治疗会导致发病率和死亡率增加。本研究旨在调查牛磺罗定的抗真菌活性,以评估其对临床分离株的作用。

材料与方法

本研究纳入了先前收集的临床分离株。采用肉汤微量稀释法测定两性霉素B、卡泊芬净、伏立康唑、泊沙康唑和伊曲康唑的最低抑菌浓度(MIC)。

结果

所有临床分离株对两性霉素B均表现出完全敏感性。泊沙康唑的MIC范围为8μg/mL至0.032μg/mL。伏立康唑和卡泊芬净的MIC范围分别确定为2 - 8μg/mL和0.5 - 16μg/mL。在1000μg/mL浓度的牛磺罗定中,分离株的生长被完全抑制。在显微镜观察中,在500μg/mL浓度下观察到对菌丝生长的形态学影响。

结论

总之,这是使用牛磺罗定对抗……的最新经验。然而,我们的体外研究结果需要在旨在治疗侵袭性毛霉病感染的精心设计的临床试验中得到证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/096524c1c575/CMM-8-26-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/65bf21ad9aed/CMM-8-26-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/421209982a19/CMM-8-26-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/3e328411d91d/CMM-8-26-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/096524c1c575/CMM-8-26-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/65bf21ad9aed/CMM-8-26-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/421209982a19/CMM-8-26-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/3e328411d91d/CMM-8-26-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/9548082/096524c1c575/CMM-8-26-g004.jpg

相似文献

1
Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates.牛磺罗定对毛霉目真菌的抗真菌活性:对临床分离株的体外研究。
Curr Med Mycol. 2022 Mar;8(1):26-31. doi: 10.18502/cmm.8.1.9211.
2
Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States.美国临床样本中毛霉目真菌的流行病学和抗真菌药敏性。
J Clin Microbiol. 2021 Aug 18;59(9):e0123021. doi: 10.1128/JCM.01230-21.
3
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.泊沙康唑、雷夫康唑和伏立康唑与伊曲康唑及两性霉素B相比,对239株曲霉属及其他丝状真菌临床分离株的抗真菌活性:2000年SENTRY抗菌监测项目报告
Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002.
4
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.曲霉属真菌对伏立康唑、伊曲康唑、泊沙康唑、两性霉素 B 和卡泊芬净的体外药敏试验。
Chin Med J (Engl). 2010 Oct;123(19):2706-9.
5
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.从眼部真菌病患者分离出的非烟曲霉属真菌的时间-杀菌动力学及体外抗真菌药敏性
Mycopathologia. 2016 Apr;181(3-4):225-33. doi: 10.1007/s11046-015-9969-z. Epub 2015 Nov 26.
6
In Vitro and In Vivo Evaluation of Voriconazole-Containing Antifungal Combinations against Mucorales Using a Model of Mucormycosis.使用毛霉菌病模型对含伏立康唑的抗真菌联合制剂进行体外和体内抗毛霉目真菌评价
J Fungi (Basel). 2019 Jan 8;5(1):5. doi: 10.3390/jof5010005.
7
In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles.毛霉目(毛霉亚门)临床相关成员的体外抗真菌药物耐药谱,尤其针对新型三唑类药物。
J Fungi (Basel). 2021 Apr 2;7(4):271. doi: 10.3390/jof7040271.
8
Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.从伊朗医院土壤中分离出的机会性毛霉目真菌的发生率、季节变化及抗真菌药敏性
Mycoses. 2021 Jul;64(7):780-787. doi: 10.1111/myc.13283. Epub 2021 Apr 26.
9
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.泊沙康唑、氟康唑、伊曲康唑、伏立康唑和两性霉素B对大量临床重要霉菌和酵母菌的体外活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15. doi: 10.1128/AAC.00163-06.
10
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.卡泊芬净、伊曲康唑、泊沙康唑、雷夫康唑、伏立康唑和两性霉素B对448株近期丝状真菌临床分离株的活性。
J Clin Microbiol. 2003 Aug;41(8):3623-6. doi: 10.1128/JCM.41.8.3623-3626.2003.

引用本文的文献

1
Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018-2023).临床和环境毛霉目真菌的分子流行病学、多样性及抗真菌药敏谱:伊朗一项为期五年的多中心研究(2018 - 2023年)
BMC Infect Dis. 2025 Jul 1;25(1):849. doi: 10.1186/s12879-025-11189-7.
2
The successful healing effect of local Taurolidine irrigation for treating deep pressure ulcers: a case report.局部使用牛磺罗定冲洗治疗深部压疮的成功疗效:一例病例报告。
J Med Case Rep. 2025 Feb 19;19(1):63. doi: 10.1186/s13256-025-05094-5.
3
The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer.

本文引用的文献

1
The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.含牛磺罗定的封管液预防中心静脉导管相关血流感染的疗效:系统评价和荟萃分析。
J Hosp Infect. 2022 May;123:143-155. doi: 10.1016/j.jhin.2021.10.022. Epub 2021 Nov 9.
2
The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.最佳解决方案:一项观察性研究,比较了透析患者中心静脉导管中使用牛磺罗定与柠檬酸盐封管液的效果。
BMC Nephrol. 2021 Sep 13;22(1):308. doi: 10.1186/s12882-021-02519-3.
3
南非植物紫花垂笑君子兰治疗三阴性乳腺癌的潜力。
Sci Rep. 2025 Feb 17;15(1):5737. doi: 10.1038/s41598-025-88417-2.
4
The Effectiveness of Taurolidine Antimicrobial Locks in Preventing Catheter-Related Bloodstream Infections (CRBSIs) in Children Receiving Parenteral Nutrition: A Case Series.牛磺罗定抗菌封管在预防接受肠外营养儿童导管相关血流感染(CRBSIs)中的有效性:病例系列
Antibiotics (Basel). 2024 Sep 5;13(9):847. doi: 10.3390/antibiotics13090847.
5
activity of taurolidine against clinical isolates: relevance to catheter-related bloodstream infections.牛磺罗定对临床分离株的活性:与导管相关血流感染的相关性。
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0038124. doi: 10.1128/aac.00381-24. Epub 2024 Jun 12.
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
4
Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients.枸橼酸牛磺罗定与普通肝素对血液透析患者炎症状态及透析充分性的影响
J Vasc Access. 2023 Jan;24(1):45-51. doi: 10.1177/11297298211023295. Epub 2021 Jun 11.
5
Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.新冠病毒病后毛霉菌病:大流行谱中的致命新增病种。
J Laryngol Otol. 2021 May;135(5):442-447. doi: 10.1017/S0022215121000992. Epub 2021 Apr 8.
6
Rhino-Orbital Mucormycosis Associated With COVID-19.与新型冠状病毒肺炎相关的鼻眶毛霉病
Cureus. 2020 Sep 30;12(9):e10726. doi: 10.7759/cureus.10726.
7
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.一项关于印度毛霉菌病的流行病学、危险因素、治疗和结局的多中心观察性研究。
Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15. doi: 10.1016/j.cmi.2019.11.021. Epub 2019 Dec 4.
8
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
9
Combination of amphotericin B and caspofungin in the treatment of mucormycosis.两性霉素B与卡泊芬净联合治疗毛霉病
Med Mycol Case Rep. 2019 Sep 21;26:32-37. doi: 10.1016/j.mmcr.2019.09.006. eCollection 2019 Dec.
10
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.当代毛霉病的治疗管理和临床结局:病例报告的系统评价和荟萃分析。
Int J Antimicrob Agents. 2019 May;53(5):589-597. doi: 10.1016/j.ijantimicag.2019.01.002. Epub 2019 Jan 10.